Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CERE is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024
- Institutional holders
- 2
- −227 vs. Q2 2024
- Shares held
- 472
- −153.4M (−100.0%) vs. Q2 2024
- Total value
- $20.7K
- −$6.27B (−100.0%) vs. Q2 2024
- New holders
- 0
- 1 more added
- Sold out
- 227
- 1 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 0 | $0 | 0.00% | −517−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −385−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −287−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −210−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Anchor Investment Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |